Laura E. H. Raffals, MD, MS

  • 1087 Citations
  • 19 Scopus h-Index
20042019
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Laura E. H. Raffals is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 8 Similar Profiles
Inflammatory Bowel Diseases Medicine & Life Sciences
Crohn Disease Medicine & Life Sciences
Ulcerative Colitis Medicine & Life Sciences
Colonic Pouches Medicine & Life Sciences
Pouchitis Medicine & Life Sciences
Microbiota Medicine & Life Sciences
Biological Therapy Medicine & Life Sciences
Therapeutics Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2004 2019

3 Citations (Scopus)

A Comprehensive Approach to Pouch Disorders

Quinn, K. P., Lightner, A., Faubion, W. A. & Raffals, L. E. H., Feb 21 2019, In : Inflammatory bowel diseases. 25, 3, p. 460-471 12 p.

Research output: Contribution to journalArticle

Colonic Pouches
Ulcerative Colitis
Surgical Anastomosis
Restorative Proctocolectomy
Pouchitis
2 Citations (Scopus)

An Increased Abundance of Clostridiaceae Characterizes Arthritis in Inflammatory Bowel Disease and Rheumatoid Arthritis: A Cross-sectional Study

Muñiz Pedrogo, D. A., Chen, J., Hillmann, B., Jeraldo, P., Al-Ghalith, G., Taneja, V., Davis, J. M., Knights, D., Nelson, H., Faubion, W. A., Raffals, L. & Kashyap, P. C., Apr 11 2019, In : Inflammatory bowel diseases. 25, 5, p. 902-913 12 p.

Research output: Contribution to journalArticle

Inflammatory Bowel Diseases
Arthritis
Rheumatoid Arthritis
Cross-Sectional Studies
Joint Diseases
1 Citation (Scopus)

Anti-TNF biologic therapy does not increase postoperative morbidity in pediatric Crohn's patients

Lightner, A., McKenna, N. P., Alsughayer, A., Loftus, Jr, E. V., Raffals, L. E. H., Faubion, W. A. & Moir, C., Jan 1 2019, In : Journal of pediatric surgery.

Research output: Contribution to journalArticle

Biological Therapy
Pediatrics
Morbidity
Crohn Disease
Operating Rooms
5 Citations (Scopus)

Appropriate Therapeutic Drug Monitoring of Biologic Agents for Patients With Inflammatory Bowel Diseases

Papamichael, K., Cheifetz, A. S., Melmed, G. Y., Irving, P. M., Vande Casteele, N., Kozuch, P. L., Raffals, L. E. H., Baidoo, L., Bressler, B., Devlin, S. M., Jones, J., Kaplan, G. G., Sparrow, M. P., Velayos, F. S., Ullman, T. & Siegel, C. A., Aug 1 2019, In : Clinical Gastroenterology and Hepatology. 17, 9, p. 1655-1668.e3

Research output: Contribution to journalArticle

Open Access
Drug Monitoring
Biological Factors
Inflammatory Bowel Diseases
Biological Products
Biological Therapy

Biologics and 30-Day Postoperative Complications After Abdominal Operations for Crohn's Disease: Are There Differences in the Safety Profiles?

Lightner, A. L., McKenna, N. P., Alsughayer, A., Harmsen, W. S., Taparra, K., Parker, M. E., Raffals, L. E. & Loftus, E. V., Nov 1 2019, In : Diseases of the colon and rectum. 62, 11, p. 1352-1362 11 p.

Research output: Contribution to journalArticle

Biological Products
Crohn Disease
Biological Therapy
Safety
Necrosis